Aspen Pharmacare Holdings Ltd (APNHF)
9.205
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 4.089B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -5.19% |
| Valuation | |
| PE Ratio | 15.74 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 1.795 |
| Price to Book Value | 0.8884 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.1806 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.4219 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 85.18% |
Profile
| Aspen Pharmacare Holdings Ltd is a South African-based global specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The group's commercial pharmaceuticals business comprises Sterile Focus and Regional Brands. Aspen has invested in strategically relevant manufacturing capacity and has capabilities across biological and chemical APIs, orals, liquids, topicals and steriles, at 23 manufacturing facilities on 6 continents. |
| URL | https://www.aspenpharma.com |
| Investor Relations URL | https://www.aspenpharma.com/investor-information/ |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Mid Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 20, 2023 |
Ratings
Profile
| Aspen Pharmacare Holdings Ltd is a South African-based global specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The group's commercial pharmaceuticals business comprises Sterile Focus and Regional Brands. Aspen has invested in strategically relevant manufacturing capacity and has capabilities across biological and chemical APIs, orals, liquids, topicals and steriles, at 23 manufacturing facilities on 6 continents. |
| URL | https://www.aspenpharma.com |
| Investor Relations URL | https://www.aspenpharma.com/investor-information/ |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Mid Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 20, 2023 |